ctrl K

Price Alert

Adial Pharmaceuticals Inc... (ADILW)

NASDAQ: ADILW · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Jul 27, 2023, 9:52 PM

Adial Pharmaceuticals WT EXP 073123 Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	564.00	60.5K	55.11K
Gross Profit	n/a	-564	-60.5K	-55.11K
Operating Income	-8.28M	-6.89M	-13.32M	-19.29M
Interest Income	178.66K	69.78K	63.34K	6.54K
Pretax Income	-13.2M	-7M	-12.73M	-19.52M
Net Income	-13.2M	-7M	-12.73M	-19.42M
Selling & General & Admin	5.06M	5.62M	9.14M	9.34M
Research & Development	3.23M	1.27M	4.18M	8.4M
Other Expenses	n/a	n/a	n/a	46.49K
Operating Expenses	8.28M	6.89M	13.32M	17.74M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	6.89M	13.32M	17.74M
Income Tax Expense	n/a	n/a	-502	-94.08K
Shares Outstanding (Basic)	18.59M	1.42M	1.06M	743.55K
Shares Outstanding (Diluted)	18.59M	1.42M	1.06M	743.55K
EPS (Basic)	-0.71	-4.92	-11.98	-26.12
EPS (Diluted)	-0.71	-4.91	-11.98	-26.12
EBITDA	-8.28M	-7M	-13.32M	-19.46M
EBIT	n/a	-7M	-10.27M	-19.52M
Depreciation & Amortization	n/a	564.00	564.00	55.11K